Daniel Brigham

1.3k total citations · 1 hit paper
10 papers, 719 citations indexed

About

Daniel Brigham is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Daniel Brigham has authored 10 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Genetics and 3 papers in Molecular Biology. Recurrent topics in Daniel Brigham's work include Acute Myeloid Leukemia Research (4 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Pneumonia and Respiratory Infections (3 papers). Daniel Brigham is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Pneumonia and Respiratory Infections (3 papers). Daniel Brigham collaborates with scholars based in United States and United Kingdom. Daniel Brigham's co-authors include Andrea Marra, Robert C. Armstrong, Barbara Belli, Michael F. Gardner, Patrick P. Zarrinkar, Shripad S. Bhagwat, Ruwanthi N. Gunawardane, Joyce James, Keith W. Pratz and Hitesh Patel and has published in prestigious journals such as Blood, Cancer Research and Infection and Immunity.

In The Last Decade

Daniel Brigham

8 papers receiving 706 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)

2009 474 citations Patrick P. Zarrinkar, Ruwanthi N. Gunawardane et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Brigham United States	6	385	288	175	138	98	10	719
Angelene M. Cantwell United States	16	373 1.0×	288 1.0×	111 0.6×	90 0.7×	45 0.5×	23	835
Hervé Maisonneuve France	16	146 0.4×	140 0.5×	290 1.7×	37 0.3×	32 0.3×	40	816
Arun K. Sarkar United States	12	75 0.2×	503 1.7×	88 0.5×	49 0.4×	94 1.0×	26	787
Sylvie Cochet France	13	120 0.3×	252 0.9×	129 0.7×	18 0.1×	34 0.3×	36	531
Madalina Uzunov France	15	217 0.6×	178 0.6×	63 0.4×	230 1.7×	51 0.5×	34	717
Sabine Vaganay France	8	91 0.2×	278 1.0×	49 0.3×	25 0.2×	35 0.4×	9	434
Gordon B. Ryan United Kingdom	13	432 1.1×	299 1.0×	41 0.2×	149 1.1×	105 1.1×	26	950
M. N. Metaxas Switzerland	16	445 1.2×	201 0.7×	73 0.4×	61 0.4×	11 0.1×	39	708
Sanja Vodanovic‐Jankovic United States	12	234 0.6×	147 0.5×	31 0.2×	33 0.2×	25 0.3×	14	568
Zufan Debebe United States	12	68 0.2×	327 1.1×	63 0.4×	87 0.6×	288 2.9×	17	823

Countries citing papers authored by Daniel Brigham

Since Specialization

Citations

This map shows the geographic impact of Daniel Brigham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Brigham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Brigham more than expected).

Fields of papers citing papers by Daniel Brigham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Brigham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Brigham. The network helps show where Daniel Brigham may publish in the future.

Co-authorship network of co-authors of Daniel Brigham

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Brigham. A scholar is included among the top collaborators of Daniel Brigham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Brigham. Daniel Brigham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Brigham, Daniel. (2016). Propositional Content, by Peter Hanks. Oxford University Press, 2015, x + 227 pp. ISBN 978‐0‐19‐968489‐2 hb £30.00. European Journal of Philosophy. 25(1). 184–189. 1 indexed citations

2.

Liu, Gang, Sunny Abraham, Xing Liu, et al.. (2015). Discovery and optimization of a highly efficacious class of 5-aryl-2-aminopyridines as FMS-like tyrosine kinase 3 (FLT3) inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(17). 3436–3441. 16 indexed citations

3.

Liu, Gang, Brian T. Campbell, Mark W. Holladay, et al.. (2012). Discovery of AC710, a Globally Selective Inhibitor of Platelet-Derived Growth Factor Receptor-Family Kinases. ACS Medicinal Chemistry Letters. 3(12). 997–1002. 10 indexed citations

4.

Gunawardane, Ruwanthi N., Daniel Brigham, Jill M. Ricono, et al.. (2010). Abstract 3619: Inhibition of FLT3 autophosphorylation and downstream signaling both in vitro and in vivo by AC220, a second generation potent and selective FLT3 inhibitor. Cancer Research. 70(8_Supplement). 3619–3619. 1 indexed citations

5.

Belli, Barbara, Daniel Brigham, Michael A. Breider, Shripad S. Bhagwat, & Robert Armstrong. (2009). Abstract #2335: AC220, a uniquely potent and selective FLT3 inhibitor, provides sustained protection in a FLT3 ITD driven model of acute myeloid leukemia. Cancer Research. 69. 2335–2335.

6.

Zarrinkar, Patrick P., Ruwanthi N. Gunawardane, Merryl Cramer, et al.. (2009). AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML). Blood. 114(14). 2984–2992. 474 indexed citations breakdown →

7.

Brigham, Daniel, Barbara Belli, Michael A. Breider, et al.. (2009). AC220, a FLT3 Inhibitor, Increases Survival in Two Genotypically Distinct FLT3-ITD Models of Acute Myeloid Leukemia and Provides Sustained Protection Following Chronic Administration.. Blood. 114(22). 2053–2053. 3 indexed citations

8.

Marra, Andrea, Jyoti Asundi, Magdalena Bartilson, et al.. (2002). Differential Fluorescence Induction Analysis of Streptococcus pneumoniae Identifies Genes Involved in Pathogenesis. Infection and Immunity. 70(3). 1422–1433. 79 indexed citations

9.

Marra, Andrea, et al.. (2002). In vivo characterization of the psa genes from Streptococcus pneumoniae in multiple models of infection. Microbiology. 148(5). 1483–1491. 92 indexed citations

10.

Marra, Andrea & Daniel Brigham. (2001). Streptococcus pneumoniae Causes Experimental Meningitis following Intranasal and Otitis Media Infections via a Nonhematogenous Route. Infection and Immunity. 69(12). 7318–7325. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact